Abstract :

Background: Leptospirosis is a globally important zoonotic disease and a leading cause of preventable mortality in Sri Lanka, with deaths driven by occupational and environmental exposure, delayed care-seeking, late clinical recognition and severe complications.

Methods: A descriptive secondary data analysis was conducted using the national leptospirosis death review database of the Epidemiology Unit, Ministry of Health, Sri Lanka. The analysis included 206 valid death records reported during 2025 through institutional death review forms.

Results: The median age was 53 years (IQR 41.5–61.5; range 16–84). Males accounted for 168/205 deaths (82.0%). The largest age group was 45–59 years (79/205, 38.5%). The highest numbers of deaths were reported from Kurunegala (34/206, 16.5%), Gampaha (19/206, 9.2%) and Rathnapura (16/206, 7.8%). Fever (155/198, 78.3%), headache (121/198, 61.1%), myalgia (115/198, 58.1%) and anuria/oliguria (93/198, 47.0%) were the most commonly documented features. Paddy field exposure was recorded in 68/206 (33.0%) of deaths. The median time from symptom onset to admission was 3 days, and the median time from symptom onset to death was 7 days. Among death review findings, late presentation or delayed treatment-seeking was the most frequent theme (75/87, 86.2%).

Conclusions: These findings highlight opportunities to reduce leptospirosis deaths in Sri Lanka through earlier detection, prompt evidence-based treatment supported by regular clinician training, targeted risk communication for high-risk populations, improved chemoprophylaxis uptake, timely referral, and strengthened access to critical care and renal support services.

---

Keywords :

death audit, Epidemiology Unit., Leptospirosis, Mortality, secondary data analysis, Sri Lanka., Surveillance

---

References :

1. World Health Organization. Human leptospirosis: guidance for diagnosis, surveillance and control. Geneva: World Health Organization; 2003.
2. Epidemiology Unit, Ministry of Health, Sri Lanka. Leptospirosis [disease information]. Colombo: Epidemiology Unit.
3. Epidemiology Unit, Ministry of Health, Sri Lanka. National Guideline on Management of Leptospirosis. Colombo: Epidemiology Unit.
4. Epidemiology Unit, Ministry of Health, Sri Lanka. Interim Guideline on Leptospirosis for Paddy Cultivating Seasons. Colombo: Epidemiology Unit; 2024.
5. Fonseka CL, Dahanayake NJ, Mihiran DJD, Wijesinghe KM, Liyanage LN, Wickramasuriya HS, et al. Pulmonary haemorrhage as a frequent cause of death among patients with severe complicated leptospirosis in Southern Sri Lanka. PLoS Neglected Tropical Diseases. 2023;17(10):e0011352.
6. Epidemiology Unit, Ministry of Health, Sri Lanka. Weekly Epidemiological Report: Leptospirosis and early warning systems. 2025;52(15).
7. Rajapakse S, Fernando N, Dreyfus A, Smith C, Rodrigo C. Leptospirosis. Nature Reviews Disease Primers. 2025;11:32.
8. Costa F, Hagan JE, Calcagno J, Kane M, Torgerson P, Martinez-Silveira MS, Stein C, Abela-Ridder B, Ko AI. Global morbidity and mortality of leptospirosis: a systematic review. PLoS Neglected Tropical Diseases. 2015;9(9):e0003898.
9. Torgerson PR, Hagan JE, Costa F, Calcagno J, Kane M, Martinez-Silveira MS, et al. Global burden of leptospirosis: estimated in terms of disability-adjusted life years. PLoS Neglected Tropical Diseases. 2015;9(10):e0004122.
10. Taylor AJ, Paris DH, Newton PN. A systematic review of the mortality from untreated leptospirosis. PLoS Neglected Tropical Diseases. 2015;9(6):e0003866.
11. Warnasekara JN, Agampodi S. Leptospirosis in Sri Lanka. Sri Lankan Journal of Infectious Diseases. 2017;7(2):67–75.
12. Agampodi S, Peacock SJ, Thevanesam V. The potential emergence of leptospirosis in Sri Lanka. Lancet Infectious Diseases. 2009;9(9):524–526.
13. Schønning MH, Phelps MD, Warnasekara J, Agampodi SB, Furu P. A case-control study of environmental and occupational risks of leptospirosis in Sri Lanka. EcoHealth. 2019;16(3):534–543.
14. Gunathilaka N, Jayakody D, Erathna S. Spatiotemporal patterns and climate influences on leptospirosis in Sri Lanka from 2009 to 2024. BMC Infectious Diseases. 2026;26 [epub ahead of print].
15. Takafuji ET, Kirkpatrick JW, Miller RN, Karwacki JJ, Kelley PW, Gray MR, et al. An efficacy trial of doxycycline chemoprophylaxis against leptospirosis. New England Journal of Medicine. 1984;310(8):497–500.
16. Fonseka CL, et al. Doxycycline usage for prevention of leptospirosis among farmers and reasons for failure to use chemoprophylaxis: a descriptive study from Southern Sri Lanka. Journal of Tropical Medicine. 2019;2019:2917154.
17. Julien M, Rafat C, Raffray L, Vacher-Coponat H, Allou N, Allyn J, Jabot J, Lombardi Y. Immediate or delayed initiation of renal replacement therapy in patients with leptospirosis and acute kidney injury: a target trial emulation. Annals of Intensive Care. 2025;15 [epub ahead of print].
18. Reller ME, Bodinayake C, Nagahawatte A, Devasiri V, Kodikara-Arachichi W, Strouse JJ, et al. Unsuspected dengue and acute febrile illness in rural and semi-urban southern Sri Lanka. Emerging Infectious Diseases. 2012;18(2):256–263.
19. Rajapaksha RMNU, et al. Health seeking behaviours, dengue prevention behaviours and community capacity for sustainable dengue prevention in a highly dengue endemic area, Sri Lanka. BMC Public Health. 2023;23.